Pogalizumab Biosimilar - Anti-ACT35 antigen mAb - Research Grade, Human Humanized, Monoclonal
Artikelnummer:
PTG-PX-TA1923-100
- Bilder (0)
| Artikelname: | Pogalizumab Biosimilar - Anti-ACT35 antigen mAb - Research Grade, Human Humanized, Monoclonal |
| Artikelnummer: | PTG-PX-TA1923-100 |
| Hersteller Artikelnummer: | PX-TA1923-100 |
| Alternativnummer: | PTG-PX-TA1923-100 |
| Hersteller: | ProteoGenix |
| Wirt: | Human Humanized |
| Kategorie: | Antikörper |
| Spezies Reaktivität: | Human |
| Alternative Synonym: | Anti-CD134, Anti-TNFRSF4, Anti-OX40, Vonlerolizumab, MOXR-0916, MOXR0916, RG-7888, RO7021608, CAS: 1638935-72-4 |
| Klonalität: | Monoclonal |
| UniProt: | P43489 |
| Puffer: | 0.01M PBS, pH 7.4. |
| Expression System: | Eukaryotic expression |
| Target-Kategorie: | CD134/OX40 |
Produktgarantie und fachkundiger Support
